Insider Stock Trading History of Cartt Stephen Lahue


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Cartt Stephen Lahue since year 2005. The trader's CIK number is 1321073. At the time of this reporting, Cartt Stephen Lahue is the President and CEO of Asterias Biotherapeutics, Inc. . (stock ticker symbol ASTY). See this page for all insider trading activities at Asterias Biotherapeutics, Inc. .

Note that in the past Cartt Stephen LaHue also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Cartt Stephen Lahue since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-06-30 AST Asterias Biotherapeutics, Inc. Buy 10,000 2.40 23,980
2016-06-10 AST Asterias Biotherapeutics, Inc. Buy 50,000 2.93 146,550
2015-08-14 BTX Biotime Inc Buy 18,400 2.65 48,760
2015-08-17 BTX Biotime Inc Buy 39,400 2.83 111,462
2015-08-18 BTX Biotime Inc Buy 17,200 2.90 49,828
2012-11-02 QCOR Questcor Pharmaceuticals Inc Buy 10,000 24.17 241,700
2011-11-08 QCOR Questcor Pharmaceuticals Inc Option Ex 8,100 5.09 41,229
2011-11-08 QCOR Questcor Pharmaceuticals Inc Sale 8,100 42.75 346,275
2011-10-28 QCOR Questcor Pharmaceuticals Inc Option Ex 139,286 2.86 398,079
2011-10-31 QCOR Questcor Pharmaceuticals Inc Sale 25,000 42.60 1,065,000
2011-10-31 QCOR Questcor Pharmaceuticals Inc Option Ex 25,000 5.09 127,250
2011-10-28 QCOR Questcor Pharmaceuticals Inc Sale 139,286 41.36 5,760,868
2011-08-15 QCOR Questcor Pharmaceuticals Inc Option Ex 47,155 1.40 66,017
2011-08-15 QCOR Questcor Pharmaceuticals Inc Sale 47,155 31.50 1,485,382
2011-08-10 QCOR Questcor Pharmaceuticals Inc Option Ex 25,000 .98 24,500
2011-08-11 QCOR Questcor Pharmaceuticals Inc Option Ex 85,968 1.43 122,934
2011-08-10 QCOR Questcor Pharmaceuticals Inc Sale 25,000 31.00 775,000
2011-08-11 QCOR Questcor Pharmaceuticals Inc Sale 85,968 31.09 2,673,174
2011-08-04 QCOR Questcor Pharmaceuticals Inc Option Ex 25,513 .98 25,002
2011-08-04 QCOR Questcor Pharmaceuticals Inc Sale 25,513 30.17 769,727
2011-05-13 QCOR Questcor Pharmaceuticals Inc Option Ex 70,400 .81 56,812
2011-05-13 QCOR Questcor Pharmaceuticals Inc Sale 70,400 22.73 1,600,192
2011-05-16 QCOR Questcor Pharmaceuticals Inc Option Ex 79,087 .98 77,505
2011-05-16 QCOR Questcor Pharmaceuticals Inc Sale 79,087 22.04 1,743,077
2009-08-04 QCOR Questcor Pharmaceuticals Inc Sale 100,000 6.12 612,000
2009-08-03 QCOR Questcor Pharmaceuticals Inc Sale 150,000 6.05 908,250
2009-08-04 QCOR Questcor Pharmaceuticals Inc Option Ex 100,000 .46 46,000
2009-08-03 QCOR Questcor Pharmaceuticals Inc Option Ex 150,000 .46 69,000
2008-12-10 QCOR Questcor Pharmaceuticals Inc Option Ex 100,000 .46 46,000
2008-12-10 QCOR Questcor Pharmaceuticals Inc Sale 100,000 9.50 950,000
2008-05-30 QCOR Questcor Pharmaceuticals Inc Sale 100,000 5.30 530,000
2008-05-30 QCOR Questcor Pharmaceuticals Inc Option Ex 100,000 .46 46,000
2008-03-18 QSC Questcor Pharmaceuticals Inc Sale 100,000 4.01 401,000
2007-12-10 QSC Questcor Pharmaceuticals Inc Sale 49,602 6.00 297,860
2007-12-12 QSC Questcor Pharmaceuticals Inc Sale 75,000 5.75 431,250
2005-10-31 QSC Questcor Pharmaceuticals Inc Buy 35,400 .64 22,656

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cartt Stephen Lahue (President and CEO of Asterias Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.